Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Midterm safety and efficacy of elective drug-coated balloon angioplasty in comparison to drug-eluting stents for unrestrictive de novo coronary lesions: A single center retrospective study.
Yamada K, Ishikawa T, Nakamura H, Mizutani Y, Ukaji T, Shimura M, Kondo Y, Aoki H, Hisauchi I, Itabashi Y, Nakahara S, Kobayashi S, Taguchi I. Yamada K, et al. Among authors: taguchi i. J Cardiol. 2023 Jun;81(6):537-543. doi: 10.1016/j.jjcc.2022.11.014. Epub 2022 Dec 6. J Cardiol. 2023. PMID: 36481299
Clinical and Angiographic Outcomes of Elective Paclitaxel-Coated Balloon Angioplasty in Comparison with Drug-Eluting Stents for De Novo Coronary Lesions in Large Vessels.
Nakamura H, Ishikawa T, Mizutani Y, Yamada K, Ukaji T, Kondo Y, Shimura M, Aoki H, Hisauchi I, Itabashi Y, Nakahara S, Kobayashi S, Taguchi I. Nakamura H, et al. Among authors: taguchi i. Int Heart J. 2023;64(2):145-153. doi: 10.1536/ihj.22-498. Int Heart J. 2023. PMID: 37005310 Free article.
Prognostic Impacts of CHADS2, CHA2DS2-VASc, and CHA2DS2-VASc-HS Scores on Clinical Outcomes After Elective Drug-Eluting Stent Placement for De Novo Coronary Stenosis.
Ukaji T, Ishikawa T, Nakamura H, Mizutani Y, Yamada K, Shimura M, Kondo Y, Tamura Y, Koshikawa Y, Hisauchi I, Nakahara S, Itabashi Y, Kobayashi S, Taguchi I. Ukaji T, et al. Among authors: taguchi i. Circ Rep. 2023 Mar 15;5(4):123-132. doi: 10.1253/circrep.CR-22-0120. eCollection 2023 Apr 10. Circ Rep. 2023. PMID: 37025938 Free PMC article.
Deep learning-based model detects atrial septal defects from electrocardiography: a cross-sectional multicenter hospital-based study.
Miura K, Yagi R, Miyama H, Kimura M, Kanazawa H, Hashimoto M, Kobayashi S, Nakahara S, Ishikawa T, Taguchi I, Sano M, Sato K, Fukuda K, Deo RC, MacRae CA, Itabashi Y, Katsumata Y, Goto S. Miura K, et al. Among authors: taguchi i. EClinicalMedicine. 2023 Aug 17;63:102141. doi: 10.1016/j.eclinm.2023.102141. eCollection 2023 Sep. EClinicalMedicine. 2023. PMID: 37753448 Free PMC article.
Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA).
Tanaka A, Taguchi I, Hisauchi I, Yoshida H, Shimabukuro M, Hongo H, Ishikawa T, Kadokami T, Yagi S, Sata M, Node K; DIANA study investigators. Tanaka A, et al. Among authors: taguchi i. Eur J Med Res. 2023 Jul 17;28(1):238. doi: 10.1186/s40001-023-01208-1. Eur J Med Res. 2023. PMID: 37461063 Free PMC article.
Rationale and design of an investigator-initiated, multicenter, prospective, placebo-controlled, double-blind, randomized trial to evaluate the effects of finerenone on vascular stiffness and cardiorenal biomarkers in type 2 diabetes and chronic kidney disease (FIVE-STAR).
Tanaka A, Shibata H, Imai T, Yoshida H, Miyazono M, Takahashi N, Fukuda D, Okada Y, Teragawa H, Suwa S, Kida K, Moroi M, Taguchi I, Toyoda S, Shimabukuro M, Tanabe K, Tanaka K, Nangaku M, Node K; FIVE-STAR trial investigators. Tanaka A, et al. Among authors: taguchi i. Cardiovasc Diabetol. 2023 Jul 31;22(1):194. doi: 10.1186/s12933-023-01928-y. Cardiovasc Diabetol. 2023. PMID: 37525257 Free PMC article. Clinical Trial.
190 results